These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3487646)

  • 21. Induction of DNA-antibodies by d-penicillamine.
    Webb J; Pollard KM
    Clin Exp Rheumatol; 1985; 3(3):213-9. PubMed ID: 3876900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
    Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
    J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dermatopolymyositis induced by D-penicillamine in rheumatoid polyarthritis. Apropos of 1 case with review of the literature].
    Kolsi R; Bahloul Z; Hachicha J; Gouiaa R; Jarraya A
    Rev Rhum Mal Osteoartic; 1992 May; 59(5):341-4. PubMed ID: 1411195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rheumatoid arthritis with antinuclear factor. A prospective study of 50 cases (author's transl)].
    Bardin T; Dryll A; Debeyre N; Peltier AP; Ryckewaert A
    Nouv Presse Med; 1982 Feb; 11(7):501-4. PubMed ID: 6977762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome.
    Saudan-Kister A; Gabay C; Tiercy JM; Mermillod B; Guerne PA; Vischer TL
    Rev Rhum Engl Ed; 1996 May; 63(5):313-20. PubMed ID: 8789876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
    Dreher R; Helmke K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
    [No Abstract]   [Full Text] [Related]  

  • 27. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
    De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F
    Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced anticentromere antibody?
    Haberhauer G; Bröll H
    Z Rheumatol; 1989; 48(2):99-100. PubMed ID: 2786663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug effects on autoantibodies and immune complexes.
    Holborow EJ
    Agents Actions Suppl; 1980; 7():58-61. PubMed ID: 6972690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
    Quismorio FP; Beardmore T; Kaufman RL; Mongan ES
    Clin Exp Immunol; 1983 May; 52(2):333-40. PubMed ID: 6602676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].
    Broggini M; Baratelli E; Cappelli A; Crespi E; Filardi PG; Volontè S
    Minerva Med; 1990 Mar; 81(3):197-201. PubMed ID: 2138721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis.
    Chalmers A; Thompson D; Stein HE; Reid G; Patterson AC
    Ann Intern Med; 1982 Nov; 97(5):659-63. PubMed ID: 6958210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillamine induced lupus-like syndrome in a patient with classical rheumatoid arthritis.
    Chin GL; Kong NC; Lee BC; Rose IM
    J Rheumatol; 1991 Jun; 18(6):947-8. PubMed ID: 1895285
    [No Abstract]   [Full Text] [Related]  

  • 35. [Retrospective study of the effects of D-penicillamine and pyrithioxin in the treatment of rheumatoid arthritis].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):281-7. PubMed ID: 6879095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody.
    Jenkins EA; Hull RG; Thomas AL
    Br J Rheumatol; 1993 Dec; 32(12):1109-10. PubMed ID: 8252325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis.
    Vardi P; Brik R; Barzilai D; Lorber M; Scharf Y
    J Rheumatol; 1992 Oct; 19(10):1527-30. PubMed ID: 1464863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
    Camus JP; Crouzet J; Prier A; Leca AP
    Therapie; 1976; 31(3):385-97. PubMed ID: 136767
    [No Abstract]   [Full Text] [Related]  

  • 39. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.